Closure of Trading Window
Dear Sir, This is to inform that Pursuant to the Code of Conduct for Prevention of Insider Trading in the shares of the Company, the Trading Window for dealing in the shares of the Company will remain closed for all the designated employees and directors from 3rd November, 2018 to 16th November, 2018 (both days inclusive). Board Meeting Intimation for This Is To Inform That The Meeting Of The Board Of Directors Of The Company Will Be Held On Wednesday, November 14, 2018 At 5.00 P.M. At The Registered Office Of The Company At 629-A Gazdar House, 1St Floor, J.S.S. Marg, Near Kalbadevi Post Office, Mumbai - 400002, Inter Alia, To Consider And Approve Unaudited Results Of The Company For The Quarter And Half Year Ended 30Th September, 2018.
VEERHEALTH CARE LIMITEDhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/11/2018 ,inter alia, to consider and approve Unaudited results of the Company for the quarter and half year ended 30th September, 2018 Compliances
Dear Sir, Pursuant to Regulation 40(9) of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, we are enclosing herewith a Certificate submitted by M/s. Nidhi Shah & Associates, Practicing Company Secretary, for the half year ended September 30, 2018. Shareholding for the Period Ended September 30, 2018
Veerhealth Care Ltd has submitted to BSE the Shareholding Pattern for the Period Ended September 30, 2018. For more details, kindly Click here Statement Of Investor Complaints For The Quarter Ended September 2018
No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0000 Name of the Signatory :- Bhavin S. ShahDesignation :- Director Announcement Under Regulation 30 (LODR)-Updates
Dear Sir, This is to inform that Company has successfully shifted its Factory from Ahmedabad to Vapi. Company has also received permission from FDA and has commenced Production of Ayurvedic and cosmetic products at Vapi from today. Compliances-Compliance Certificate For The Period Ended September 30, 2018
Dear Sir, Pursuant to Regulation 7(3) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we are enclosing herewith a Certificate, duly signed by Share Transfer Agent and the Compliance Officer of the Company for the half year ended September 30, 2018 in compliance of Regulation 7(2) of SEBI Listing Regulations, 2015. Disclosure of Voting results of AGM (Regulation 44(3) of SEBI (LODR) Regulations, 2015)
Veerhealth Care Ltd has informed BSE regarding the details of Voting results of AGM, under Regulation 44(3) of SEBI (LODR) Regulations, 2015. Kindly Click here Shareholder Meeting / Postal Ballot-Scrutinizer''s Report
Dear Sir, In terms of Regulation 44(3) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we are submitting herewith the details regarding the voting results of the business transacted at the 26th Annual General Meeting of the Company. Further, we are also enclosing the Consolidated Report of the Scrutinizer of e-voting and voting at the 26th Annual General Meeting of the Company.... Shareholder Meeting / Postal Ballot-Outcome of AGM
Dear Sir, The Company's 26th Annual General Meeting (AGM) was held today i.e. on Friday, 28th September, 2018. In terms of Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 we write to inform you that the following items have been transacted at the AGM: Ordinary Business: 1. To consider and adopt the audited financial statements of the Company for the financial year ended March 31, 2018...